Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study.
Vergouwen
Mervyn D I
MD
Vermeulen
M
M
Roos
Yvo B W E M
YB
D001777:Blood Coagulation / Q000187:drug effects / Q000502:physiology; D001778:Blood Coagulation Disorders / Q000139:chemically induced / Q000503:physiopathology; D020520:Brain Infarction / Q000139:chemically induced / Q000503:physiopathology / Q000517:prevention & control; D015984:Causality; D002536:Cerebral Arteries / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D002543:Cerebral Hemorrhage / Q000139:chemically induced* / Q000503:physiopathology / Q000517:prevention & control; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D006937:Hypercholesterolemia / Q000188:drug therapy*; D007049:Iatrogenic Disease / Q000517:prevention & control; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy*; D020521:Stroke / Q000188:drug therapy* / Q000517:prevention & control*
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors